Infusion Pump Market Size, Share, Opportunities, And Trends By Type (Insulin Pump, PCA Pump, Enteral Pump), By Mechanism (Syringe Pump, Elastomeric Pump, Peristaltic Pump, Multi-Channel Pump, Smart Pump), By Application (Chemotherapy, Gastroenterology, Diabetes, Pain Management, Haematology, Others), And By Geography - Forecasts From 2024 To 2029

The infusion pump market is expected to grow at a CAGR of 5.71% from US$9.547 billion in 2022 to US$14.083 billion in 2029.

Infusion pumps play a crucial role in the medical field, efficiently delivering controlled amounts of fluids, such as medications and nutrients, into patients' bodies. Widely utilized in diverse settings like hospitals, nursing homes, and even at home, these devices offer numerous advantages over manual administration. It is often operated by trained users, infusion pumps work in a user-friendly software interface that allows precise programming of fluid delivery rates and durations. This capability enables the delivery of fluids in small volumes and at automated intervals, enhancing accuracy and reliability in medical treatments. The range of substances administered through infusion pumps includes vital medications like insulin, hormones, antibiotics, chemotherapy drugs, and pain relievers.

Various types of infusion pumps cater to specific needs, including large-volume pumps, patient-controlled analgesia (PCA) pumps, elastomeric pumps, syringe pumps, enteral pumps, and insulin pumps. Some pumps are stationary and primarily bedside-based, while others, known as ambulatory infusion pumps, are designed to be portable or wearable for greater flexibility.

Infusion pumps may be powered either electrically or mechanically, and their operational mechanisms vary across different types. For instance, in syringe pumps, a moveable piston controls fluid delivery within a syringe reservoir. Elastomeric pumps utilize a stretchable balloon reservoir, where pressure from the elastic balloon walls propels fluid delivery. Peristaltic pumps employ a set of rollers to pinch down on flexible tubing, pushing fluid forward. Meanwhile, multi-channel pumps allow the delivery of fluids from multiple reservoirs at distinct rates. Overall, the versatility and precision of infusion pumps make them indispensable tools in modern healthcare.

Market Drivers

• Rise in healthcare expenditure

The World Health Organization (WHO) has expressed concern about the escalating toll of non-communicable diseases (NCDs), projecting that if current trends persist, chronic conditions like cardiovascular diseases, cancer, diabetes, and respiratory illnesses will constitute a staggering 86% of the 90 million annual deaths by around 2050. The prevalence of many chronic diseases is attributed to a concise list of risk behaviours, including tobacco use and exposure to secondhand smoke, inadequate nutrition marked by low fruit and vegetable intake and high sodium and saturated fat consumption, physical inactivity, and excessive alcohol use. In response to the escalating prevalence of chronic diseases, governments worldwide are witnessing a notable rise in healthcare spending. This financial commitment is driven by the cause to address the complex factors contributing to NCDs.

In the United States, health spending experienced a 2.7% increase in 2021, reaching $4.3 trillion or $12,914 per capita. Although this growth rate is notably lower than that of 2020 (10.3%), it underscores the significant financial burden of addressing the rising prevalence of chronic diseases.

Among European Union Member States, Germany leads in current healthcare expenditure, reaching €432 billion in 2020, followed by France at €281 billion, Italy at €160 billion, and Spain at €120 billion. Germany and France's healthcare expenditures accounted for 12.8% and 12.2% of their respective gross domestic product (GDP). These figures underscore the growing financial commitment by governments to address the healthcare challenges posed by the increasing prevalence of chronic ailments and evolving lifestyles.

These trends in healthcare spending are intricately linked with the broader healthcare market, influencing the demand for medical technologies such as infusion pumps. The evolving landscape underscores the imperative of adapting healthcare systems to effectively manage the rising burden of chronic diseases.

• Growing geriatric population

The global landscape is currently undergoing significant transformations due to demographic shifts. In the Asia-Pacific (APAC) region, the proportion of individuals aged 60 or older was approximately 12.4% in 2016. Projections indicate a substantial increase, exceeding a quarter of the population, or 1.3 billion people, by the year 2050. This demographic transition highlights the escalating healthcare demands in the region, particularly in east and north Asia, which includes countries like Japan and the Republic of Korea, where over a third of the population is expected to be aged 60 or older by 2050.

Similarly, the European Union (EU) is witnessing a direct correlation between its aging population and the demand for infusion pumps. The population of individuals aged 65 or more in the EU-27 is poised for a significant surge, rising from 90.5 million in 2019 to 129.8 million by 2050. Within this timeframe, the segment aged 75-84 years is projected to experience a notable growth of 56.1%, while the group aged 65-74 years is anticipated to increase by 16.6%.

In the United States, the growth in the older population has seen a remarkable spike from 2010 to 2020, with a growth rate of 38.6%, soaring from 40.3 million to 55.8 million. This growth is more than twice as fast as the previous decade, highlighting a significant demographic shift.

Within the context of the infusion pump market and healthcare, a discernible global trend emerges where the older population is expanding at an accelerated rate. This underscores the rising importance of healthcare technologies, including the demand for infusion pumps, as indispensable components in addressing the evolving healthcare needs associated with the aging global population.

Market Challenges

• Product recalls as a challenge to the market

Infusion pumps, and intricate medical devices, pose inherent risks of malfunction or software defects, potentially leading to product recalls and causing significant financial and reputational damage to manufacturers. A recent illustration of such challenges occurred in September 2023, when Becton Dickinson (BD)/Carefusion 303 initiated a recall of Alaris Infusion Pumps due to compatibility issues with Cardinal Health Monoject Syringes. The Alaris infusion pump, designed as a modular system, is primarily intended for the precise delivery of medications or other fluids. Notably, the syringe and PCA pump modules undergo validation for use exclusively with specific syringes, highlighting the critical nature of ensuring compatibility to avoid adverse incidents and maintain the integrity of healthcare delivery systems.

• By type, the infusion pump market is segmented into insulin pump, PCA pump, enteral pump

The infusion pump market is segmented into insulin, PCA, and enteral pumps, each serving distinct medical needs. Patient-controlled analgesia (PCA) pumps offer patient autonomy in administering pain medication. Insulin pumps, commonly used in homes, provide a controlled delivery system for diabetes management. An enteral pump is employed to administer liquid nutrients and medications directly to a patient's digestive tract.  

North America is anticipated to hold a significant share of the Infusion Pump Market

North America is poised to command a notable share in the Infusion Pump Market. Recent data from the American Hospital Association underscores the resilience of the U.S. healthcare landscape, with a notable increase in the total count of U.S. hospitals from 6,093 in 2022 to 6,129 in 2023. The scale of medical activities is emphasized by the cumulative hospital admissions, reaching 34,011,386 in 2023, with 33,356,853 admissions recorded in 2022. Canada is witnessing a significant trajectory in health spending, projected to reach $331 billion in 2022, or $8,563 per Canadian. Anticipated growth in spending is driven by deferred care returning post-pandemic, contributing to an increase in healthcare services. Demographic factors, including population aging and growth, further fuel spending growth, fostering a conducive environment for overall healthcare facilities, including infusion pumps.

Market Developments

• August 2023-  ICU Medical attained FDA clearance for its Plum Duo™ Infusion Pump and LifeShield™ Infusion Safety Software. The regulatory green light, received through the 510(k) clearance process, marks a significant milestone for the company. The Plum Duo pump, set to be available in the U.S. in early 2024, expands ICU Medical's infusion device portfolio. Leveraging cassette technology from the award-winning Plum 360™, it boasts a large color touch screen and an intuitive interface. With two channels capable of delivering up to four compatible IV medications, the Plum Duo enhances precision in medication delivery, emphasizing the company's commitment to advancing infusion pump technology.
• June 2023- Cedars-Sinai Cancer pioneered a game-changing treatment for patients with inoperable liver tumors resulting from colorectal cancer spread. Utilizing a distinctive chemotherapy delivery system known as hepatic artery infusion (HAI) pump chemotherapy, physicians at Cedars-Sinai provide hope to individuals facing limited options. This targeted chemotherapy approach not only reduces toxic exposure but also opens up the possibility of surgical cures for patients who would otherwise have few alternatives.
• April 2023- EItan Medical, a prominent global player in advanced infusion therapy and drug delivery solutions, unveiled its latest breakthrough – the Avoset™ connected infusion multi-therapy ambulatory system. This innovative system marks a significant leap in post-acute care and specialty infusion therapy, offering a compact and simplified technological solution. The Avoset™ Infusion System is uniquely designed to enable remote monitoring of infusion treatment data, placing a heightened focus on patient safety.

Company Products

• Spectrum IQ-  The Spectrum IQ Infusion System represents a significant advancement in infusion pump technology, building upon the proven foundation of the Spectrum infusion pump. This comprehensive system prioritizes patient safety by ensuring drug library compliance, safeguarding high-risk infusions, and consistently enabling auto-programming within health systems. Notably, it enhances Electronic Medical Record (EMR) integration through intelligent design features.
• BD BodyGuard™ infusion pumps - BD BodyGuard™ infusion pumps encompass a range of versatile and reliable medical devices designed to meet various healthcare needs. Such as the BD BodyGuard™ T syringe pump, known for its compact and lightweight design, provides ambulatory infusion capabilities, offering flexibility and dependability. Meanwhile, the BD BodyGuard™ Epidural infusion pump specializes in specific pain management modes, aiming to enhance patient comfort and overall quality of life.
• Infusomat® Space® Large Volume Pump - The Infusomat® Space® Large Volume Pump stands as an integral tool in acute care settings for both adult and pediatric patients. Weighing a mere 3 pounds, its intelligent and compact design ensures flexibility and effortless transport across various care environments. Specifically engineered for versatility, the Infusomat Space offers cutting-edge features that enhance efficiency in a multitude of medical settings, including the ICU, CCU, NICU, PICU, OR, Med Surg, Emergency Department, Infusion Centers, and Outpatient Care. This infusion pump is characterized by its adaptability and portability, making it a valuable asset in delivering critical care across diverse healthcare scenarios.

Market Segmentation

• By Type
  • Insulin Pump
  • PCA Pump
  • Enteral Pump
• By Mechanism
  • Syringe Pump
  • Elastomeric Pump
  • Peristaltic Pump
  • Multi-channel Pump
  • Smart Pump
• By Application
  • Chemotherapy
  • Gastroenterology
  • Diabetes
  • Pain Management
  • Haematology
  • Others
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Taiwan
    • Indonesia
    • Thailand
    • Others

---

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Process

3. EXECUTIVE SUMMARY

3.1. Key Findings

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. INFUSION PUMP MARKET, BY TYPE

5.1. Introduction

5.2. Insulin Pump

5.3. PCA Pump

5.4. Enteral Pump

6. INFUSION PUMP MARKET, BY MECHANISM

6.1. Introduction

6.2. Syringe Pump

6.3. Elastomeric pump

6.4. Peristaltic pump

6.5. Multi-channel pump

6.6. Smart Pump

7. INFUSION PUMP MARKET, BY APPLICATION

7.1. Introduction

7.2. Chemotherapy

7.3. Gastroenterology

7.4. Diabetes

7.5. Pain management

7.6. Haematology

7.7. Others

8. INFUSION PUMP MARKET, BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. Germany

8.4.2. France

8.4.3. UK

8.4.4. Others

8.5. Middle East & Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Taiwan

8.6.6. Thailand

8.6.7. Indonesia

8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

10. COMPANY PROFILES

9.1 Baxter International Inc.

9.2 Becton, Dickinson and Company

9.3 Braun Melsungen AG

9.4 Johnson & Johnson

9.5 Medtronic Inc.

9.6 Nipro Corporation

9.7 Biomedix Medical

9.8 Eitan Medical

9.9 Smiths Medical

9.10 Terumo Corporation

Baxter International Inc.

Dickinson and Company

Braun Melsungen AG

Johnson & Johnson

Medtronic Inc.

Nipro Corporation

Biomedix Medical

Eitan Medical 

Smiths Medical

Terumo Corporation